INVIVO THERAPEUTICS HOLDINGS CORP. | 2013 | FY | 3


18. INSURANCE CLAIM

        During the year ended December 31, 2013, the Company received insurance proceeds of approximately $1,100,000 from the settlement of a business interruption claim that covered the disruption of the Company's operations at its facility in Cambridge, MA caused by water damage that occurred in November 2012. The insurance settlement reimbursed the Company for costs incurred as a result of the disruption is included as reduction of Research and Development Expense in the Consolidated Statement of Operations for the year ended December 31, 2013.


us-gaap:BusinessInsuranceRecoveriesTextBlock